- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02656784
The Efficacy of TBCT Compared to ERP in the Treatment of OCD Patients, by the Assessment of Magnetic Resonance.
The Resonance Assessment in Magnetic Measurement of the Effect of Psychotherapy in Obsessive-compulsive Disorder in a Randomized Clinical Trial
This is a sample made up of ninety-six adult individuals of both sexes to be divided into three groups: the experimental group of thirty-two patients with OCD who will be undergone Trial-Based Cognitive Therapy; the gold standard, with thirty-two people with OCD subject Exposure and Response Prevention and the control group of thirty-two healthy individuals. Interviews and therapeutic intervention occur in private practices researchers or medical schools accredited by UESPI.
Experimental group: Will be eligible adults of both sexes with educational level equal to or higher education complete primary, aged between 18 and 60 years with OCD diagnosis confirmed according to criteria DSM-IV (APA, 1994). It is going to be excluded patients who had previously undergone treatment behavioral psychotherapy or cognitive-behavioral approach.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
OBJECTIVES
Evaluate the effectiveness of Trial-Based Cognitive Therapy (TBCT) compared to Exposure and Response Prevention (ERP) in the treatment of OCD patients, by neuroimaging tests such as MRI.
- Describe the neuroanatomical profile of the sample participants before and after the psychotherapeutic intervention by MRI;
- Compare the profile neuroanatomical between the experimental group and the control group by MRI;
- Identify possible neuroanatomical differences in the participating sample of pre and post-treatment, both among individuals and among psychotherapeutic intervention groups;
- To investigate associations between the results of MRI scans and indexes the scales currently used to assess severity of OCD.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Piauí
-
Teresina, Piauí, Brazil, 64002-150
- Piauí State University - UESPI
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Will be eligible adults of both sexes with educational level equal to or higher education complete primary, aged between 18 and 60 years with OCD diagnosis confirmed according to criteria DSM-IV
Exclusion Criteria:
- It is going to be excluded patients who had previously undergone treatment behavioral psychotherapy or cognitive-behavioral approach.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Trial-Based Cognitive Therapy (TBCT)
Trial-Based Cognitive Therapy (TBCT) is a three-level, three-phase, case formulation approach, based on the work of Franz Kafka "The Trial" and developed by Professor Irismar Reis de Oliveira at Federal University of Bahia, Brazil.
TBCT's foundation is in cognitive therapy (CT); however, it has a unique approach to conceptualization and techniques that make it a distinct intervention in modifying patients' core beliefs, especially those about the self.
All individuals in the group will be submitted to MRI
|
The Behavioral therapy employs the technique of Exposure and Response Prevention ( ERP ).The technique involves directly exposing patients to recall stimulation of obsessive thoughts and prevent them from performing the compulsive rituals.
All the individuals will be submitted to MRI.
Other Names:
|
Experimental: Behavioral Therapy (ERP)
The Behavioral Therapy is an intervention of first choice for treatment of OCD , which employs the technique of Exposure and Response Prevention (ERP) , considered the gold standard to the disorder.
The technique involves directly exposing patients to recall stimulation of obsessive thoughts and prevent them from performing the compulsive rituals.
All individuals in the group will be submitted to MRI
|
Trial-Based Cognitive Therapy (TBCT) is a three-level, three-phase, case formulation approach.
TBCT's foundation is in cognitive therapy (CT); however, it has a unique approach to conceptualization and techniques that make it a distinct intervention in modifying patients' core beliefs, especially those about the self.
All the individuals will be submitted to MRI.
Other Names:
|
No Intervention: Control Group
The control group consisted of individuals without OCD, matched with the experimental group in terms of gender,age and education.
In this group are not included in individuals in psychotherapeutic care and with a history of neurological or psychiatric disorder; however, all them will be submitted to MRI .
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The severity of OCD (Morphological and physiological changes in the brain)
Time Frame: 12 weeks (3 months)
|
Data colected at 1st week, 6th week, 12th week.
Scales used are Yale-Brown Obssessive Compulsive Scale and Symptoms of Checklist (Y-BOCS), Beck Depression Inventory (BDI), Beck Anxienty Inventory (BAI), Obsessive-Compulsive Beliefs Questionnaire-87 (OBQ-87), The Medical Outcomes Study 36 - Item Short Form Health Survery ( SF-36), Questionnare of Cognitive Distortions (CD-Quest), Subjective Units of Discomfort (SUDS) and MRI.
|
12 weeks (3 months)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Quality of Life
Time Frame: 12 weeks
|
Data colected at 1st week and 12th week and, at follow-up, after three months, six months and one year.
The scale used is SF-36
|
12 weeks
|
Quality of Life
Time Frame: 1 year
|
At follow-up, after three months, six months and one year.
The scale used is SF-36
|
1 year
|
Cognitive Distortions
Time Frame: 12 weeks
|
Data colected every week (during 12 weeks).
The scale used is CD-Quest
|
12 weeks
|
Cognitive Distortions
Time Frame: 1 year
|
At follow-up, after three months, six months and one year.
The scale used is Cognitive Distortions Questionnaire.
|
1 year
|
Severity of OCD
Time Frame: 12 weeks
|
Data colected at 1st week, 6th week and 12th week and, at follow-up, after three months, six months and one year.
The scale used is Y-BOCS
|
12 weeks
|
Severity of OCD
Time Frame: 1 year
|
At follow-up, after three months, six months and one year.
The scale used is Y-BOCS.
|
1 year
|
The Assessment of Depression
Time Frame: 12 weeks
|
Data colected at 1st week, 6th week and 12th week and, at follow-up, after three months, six months and one year.
The scale used is BDI
|
12 weeks
|
The Assessment of Depression
Time Frame: 1 year
|
At follow-up, after three months, six months and one year.
The scale used is BDI
|
1 year
|
The Assessment of Anxiety
Time Frame: 12 weeks
|
Data colected at 1st week, 6th week and 12th week and, at follow-up, after three months, six months and one year.
The scale used is BAI
|
12 weeks
|
The Assessment of Anxiety
Time Frame: 1 year
|
At follow-up, after three months, six months and one year.
The scale used is BAI
|
1 year
|
The Assessment of Magnetic Resonance (MRI)
Time Frame: 15 weeks
|
Data colected at zero week and 15th week.
The scale used is MRI
|
15 weeks
|
The Assessment of The Obssessive Beliefs
Time Frame: 15 weeks
|
Data colected at zero week and 15th week.
The scale used is OBQ-87
|
15 weeks
|
The level of Anxiety (Obssessive, Compulsive and Evitation Symptoms)
Time Frame: 12 weeks
|
Data colected every week (during 12 weeks).
The scale used is SUDS
|
12 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Eleonardo P Rodrigues, Psy MSc, Piaui State University - Brazil - UESPI - Recruiting
- Study Director: Irismar R De Oliveira, PhD, Bahia Federal University - Brazil - UFBA
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- UESPI
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on OBSESSIVE COMPULSIVE DISORDER (OCD)
-
Icahn School of Medicine at Mount SinaiNational Institute of Mental Health (NIMH)RecruitingObsessive Compulsive Disorder (OCD)United States
-
University of ArizonaActive, not recruitingObsessive-compulsive Disorder (OCD)United States
-
University of LeipzigGerman Research Foundation; Philipps University Marburg Medical CenterCompleted
-
New York State Psychiatric InstituteCompletedObsessive-Compulsive Disorder (OCD)United States
-
Baylor College of MedicineBrown University; Duke University; University of Washington; Mclean Hospital; William... and other collaboratorsNot yet recruitingObsessive-Compulsive Disorder (OCD)United States
-
New York State Psychiatric InstituteCompletedObsessive Compulsive Disorder (OCD)United States
-
The University of Texas Health Science Center,...MedtronicRecruitingObsessive-Compulsive Disorder (OCD)United States
-
Haukeland University HospitalSorlandet Hospital HFActive, not recruitingObsessive Compulsive Disorder (OCD)
-
University of BathSouth London and Maudsley NHS Foundation Trust; Avon and Wiltshire Mental Health...UnknownObsessive Compulsive Disorder (OCD)United Kingdom
-
Assistance Publique - Hôpitaux de ParisRecruitingObsessive Compulsive Disorder OCDFrance
Clinical Trials on Behavioral Therapy
-
Roswell Park Cancer InstituteCompletedColorectal Cancer | Healthy, no Evidence of DiseaseUnited States
-
Ohio State University Comprehensive Cancer CenterAmerican Cancer Society, Inc.; Lance Armstrong FoundationCompletedDepression | Pain | Leukemia | Fatigue | Multiple Myeloma | Insomnia | Pancreatic Cancer | Esophageal Cancer | Lung Cancer | Glioblastoma Multiforme | Sleep Disorders | Uncertainty | Ovarian Neoplasm | Anxiety Disorder | Psychological Intervention | Relapsed Lymphoma | Worry | Cognitive-behavioral Therapy | Stage III or IV Cervical... and other conditionsUnited States
-
Mayo ClinicJames and Esther King Biomedical Research ProgramCompletedfor Cigarette Smoking and Binge Drinking CessationUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI); University of RochesterRecruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedProstate CarcinomaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)Enrolling by invitationHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid NeoplasmUnited States
-
Jonsson Comprehensive Cancer CenterCompletedCancer Survivor | Stage I Breast Cancer AJCC v7 | Stage IA Breast Cancer AJCC v7 | Stage IB Breast Cancer AJCC v7 | Stage II Breast Cancer AJCC v6 and v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Stage IIIA Breast Cancer AJCC v7 | Stage 0 Breast Cancer AJCC...United States
-
Seinajoki Central HospitalTampere UniversityCompletedAnxiety Disorders | Major Depression | Dual Diagnosis | Substance Related DisordersFinland
-
Eleos HealthMissouri Department of Mental HealthCompletedMood Disorders | Anxiety DisordersUnited States
-
Regionsenter for barn og unges psykiske helseThe Research Council of NorwayCompletedGeneralized Anxiety Disorder | Social Phobia | Separation Anxiety DisorderNorway